Pulmonary Arterial Hypertension Panel

New York
Approved

Genes

ACVRL1, BMPR2, CAV1, EIF2AK4, ENG, GDF2, KCNK3, SMAD9

Conditions

  • Pulmonary Arterial Hypertension (PAH)

Clinical Utility

  • Confirmation of a clinical diagnosis in symptomatic individuals
  • Identification of individuals at­ risk for developing the disease
  • Recurrence risk assessment

Lab Method

  • Deletion/Duplication Analysis
  • Next-Gen Sequencing

Test Code

696

CPT Codes*

81405x2, 81406x2

ABN Required

No

Turnaround Time**

4 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.

Need something else?

Search More Tests